Table 1.

Figure abbreviations for cholestatic (red) and non-cholestatic (black) pharmaceuticals and model toxicants used in this study. Compounds were dosed via oral gavage (p.o.) unless otherwised noted (subcutaneous—s.c.; intraperitoneal—i.p.).